mouse anti-human braf v600e monoclonal antibody ve1 (Spring Bioscience)
90
Structured Review
Spring Bioscience
mouse anti-human braf v600e monoclonal antibody ve1
Mouse Anti Human Braf V600e Monoclonal Antibody Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-human+braf(v600e)+antibody%2C+ve1/braf+v600e+antibody/pmc07801318-75-5-6
Average 90 stars, based on 1 article reviews
Mouse Anti Human Braf V600e Monoclonal Antibody Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-human+braf(v600e)+antibody%2C+ve1/braf+v600e+antibody/pmc07801318-75-5-6
Average 90 stars, based on 1 article reviews
mouse anti-human braf v600e monoclonal antibody ve1 - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy"
Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy
Journal: Annals of Surgical Oncology
doi: 10.1245/s10434-020-08713-1
Figure Legend Snippet: Lymphocyte biomarkers and distribution by BRAF mutation status
Techniques Used: Mutagenesis
Figure Legend Snippet: Clinical response to DPCP correlated with OS by biomarker status
Techniques Used: Biomarker Assay
Related Articles
Mutagenesis:Article Title: BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics Article Snippet: Glomus tumors are rare mesenchymal neoplasms with a phenotype akin to the modified smooth muscle cells of the glomus body.. Most are benign, but rare examples show malignant histologic characteristics and aggressive behavior.. We recently encountered a malignant glomus tumor with BRAF V600E mutation. Expressing:Article Title: BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics Article Snippet: Glomus tumors are rare mesenchymal neoplasms with a phenotype akin to the modified smooth muscle cells of the glomus body.. Most are benign, but rare examples show malignant histologic characteristics and aggressive behavior.. We recently encountered a malignant glomus tumor with BRAF V600E mutation. Immunohistochemistry:Article Title: BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics Article Snippet: Glomus tumors are rare mesenchymal neoplasms with a phenotype akin to the modified smooth muscle cells of the glomus body.. Most are benign, but rare examples show malignant histologic characteristics and aggressive behavior.. We recently encountered a malignant glomus tumor with BRAF V600E mutation. other:Article Title: Morphological and Molecular Assessment in Thyroid Cytology Using Cell-Capturing Scaffolds. Article Snippet: Due to the use of ultrasound (US) examination, the detection of the prevalence of thyroid nodules in the general population is increasing worldwide, paralleled by a rise in the diagnosis of differentiated thyroid cancer [1].. For a large part of thyroid nodules, fine needle aspiration (FNA) biopsy followed by cytological assessment is the established procedure for a timely diagnosis and a correct planning of management [2].. About 60–70 % of thyroid nodules Endocrine Care Article Title: Quantitative analysis of wild-type and V600E mutant BRAF proteins in colorectal carcinoma using immunoenrichment and targeted mass spectrometry. Article Snippet: Immunoenrichment coupled with MRM or SIM-AIMS assay was evaluated for quantifying WT and V600E mutant BRAF proteins in CRC.. Both assays could successfully detect/ quantify both targets in a CRC cell line and CRC tissue samples.. Both targets could be quantified at the level of sub ng/mg protein Article Title: Long-Term Extracorporeal Membrane Oxygenation as Bridging Strategies to Lung Transplantation in Rapidly Devastating Isolated Langerhans Cell Histiocytosis. Article Snippet: Isolated pulmonary involvement in pediatric Langerhans cell histiocytosis (LCH) is extremely rare.. While the multisystem-LCH course varies from spontaneous remission to rapid deterioration with lethal outcome, single system involvement is generally associated with favorable prognosis.. A child with isolated pulmonary LCH had an extremely rapid progression leading to respiratory failure, despite treatment with prednisone and vinblastine. Article Title: BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin. Article Snippet: BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin Jau-Yu Liau MD, Jia-Huei Tsai MD, Wen-Chang Huang MD, Jui Lan MD, Jin-Bon Hong MD, Chang-Tsu Yuan MD PII: S0046-8177(17)30467-7 DOI: doi: 10.1016/j.humpath.2017.12.002 Reference: YHUPA 4419 To appear in: Human Pathology Received date: 26 September 2017 Revised date: 17 November 2017 Accepted date: 1 December 2017 Please cite this article as: Liau Jau-Yu, Tsai Jia-Huei, Huang Wen-Chang, Lan Jui, Hong Jin-Bon, Yuan Chang-Tsu, BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin, Human Pathology (2017), doi: 10.1016/j.humpath.2017.12.002 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Article Title: A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER SensiFAST probe No-ROX kit Bioline Cat# BIO-86005 CellTiter Glo Assay Promega Cat# G7571 Deposited data Human raw single cell RNA sequencing data This study EGA: EGAD00001009291 Human raw sequencing data from Visium 10x Genomics This study EGA: EGAD00001010921 Human processed data from malignant cells This study KU Leuven RDR: https://doi.org/10.48804/GSAXBN Human processed data from breast cancer cohort Bassez et al.30 EGA: EGAD00001006608 Processed data from melanoma brain metastases Biermann et al.37 GEO: GSE185386 Processed data from melanoma metastases before and after immunotherapy Jerby-Arnon et al.18 GEO: GSE115978 TCGA melanoma data The Cancer Genome Atlas http://firebrowse.org/?cohort= SKCM&download_dialog=true CCLE cohort Barretina et al.74 https://sites.broadinstitute.org/ccle/ Experimental models: Cell lines MM011 Dr. Ghanem Ghanem, Institute Jules Bordet N/A MM047 Dr. Ghanem Ghanem, Institute Jules Bordet N/A MM057 Dr. Ghanem Ghanem, Institute Jules Bordet N/A MM099 Dr. Ghanem Ghanem, Institute Jules Bordet N/A A375 ATCC Cat# CRL-1619 HEK293 FT ThermoFisher Scientific Cat# R70007 Ma-Mel-86c Dr. Annette Paschen, University Hospital Essen N/A B16F10 murine ATCC Cat# CRL-6475 NRAS/Ink4a-/- murine Generated in house; Karras et al.25 N/A YUMM1.7-OVA Dr. Ping-Chih Ho (University of Lausanne) N/A PBMC Precision Medicine N/A Experimental odels: Organisms/strains C57BL/6 mouse KU Leuven animal facility N/A Foxn1nu mouse Taconic Biosciences N/A OT-1 mouse: C57BL/6-Tg (TcraTcrb)1100Mjb/J Jackson Labs strain #003831 Oligonucleotides Primer list See Table S6 for the list of primers N/A Recombinant DNA FUGW vector Addgene Plasmid Cat# 14883 pLVX-CMV-ZsGreen plasmid Clontech Cat# 632187 (Continued on next page) ll OPEN ACCESS Cell 187, 166–183.e1–e15, January 4, 2024 e4 Article Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy Article Snippet: For BRAF V600E IHC, Pleasanton, |
